Embolization Efficacy and Treatment Effectiveness of Transarterial Therapy for Unresectable Hepatocellular Carcinoma: A Case-Controlled Comparison of Transarterial Ethanol Ablation with Lipiodol-Ethanol Mixture versus Transcatheter Arterial Chemoembolization

Journal of Vascular and Interventional Radiology

Volumn 20, Issue 3, 2009, Pages 352-359

  Yu, Simon C H ^a   Hui, Joyce W Y ^a   Hui, Edwin P ^a   Mo, Frankie ^a   Lee, Paul S F ^a   Wong, John ^a   Lee, Kit F ^a   Lai, Paul B S ^a   Yeo, Winnie ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CISPLATIN; GELATIN SPONGE; IODINATED POPPYSEED OIL;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; CANCER GROWTH; CANCER SURVIVAL; CHEMOEMBOLIZATION; FEMALE; HUMAN; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME; TUMOR GROWTH;

CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; CHEMOEMBOLIZATION, THERAPEUTIC; CONTRAST MEDIA; ETHANOL; FEMALE; HEPATECTOMY; HUMANS; INJECTIONS, SPINAL; IODIZED OIL; LIVER NEOPLASMS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 60649119330     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvir.2008.12.407     Document Type: Article

References (34)

1. El-Serag H.B., and Mason A.C. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 340 (1999) 745-750
2. Taylor-Robinson S.D., Thomas H.C., Arora S., and Hargreaves S. Increased mortality from liver cancer in England and Wales is not related to hepatitis C (letter). Br Med J 319 (1999) 640
3. Llovet J.M., Real M.I., Montana X., et al. Arterial embolisation or chemoembolization vs symptomatic treatment in patients with unresectable HCC: a randomised controlled trial. Lancet 359 (2002) 1734-1739
4. Lo C.M., Ngan H., Tso W.K., et al. Randomized controlled trial of transarterial Lipiodol chemoembolization for unresectable HCC. Hepatology 35 (2002) 1164-1171
5. Maluccio M.A., Covey A.M., Porat L.B., et al. Transcatheter arterial embolization with only particles for the treatment of unresectable hepatocellular carcinoma. J Vasc Interv Radiol 19 (2008) 862-869
6. Sato K.T., Lewandowski R.J., Mulcahy M.F., et al. Unresectable chemorefractory liver metastases: radioembolization with 90Y microspheres-safety, efficacy and survival. Radiology 247 (2008) 507-515
7. Matsui O., Kadoya M., Yoshikawa J., et al. Small hepatocellular carcinoma: treatment with subsegmental transcatheter arterial embolization. Radiology 188 (1993) 79-83
8. Park J.H., Han J.K., Chung J.W., Choi B.I., Han M.C., and Kim Y.I. Superselective transcatheter arterial embolization with ethanol and iodized oil for hepatocellular carcinoma. J Vasc Interv Radiol 4 (1993) 333-339
9. Ito K., Kusunoki H., Okamoto E., et al. Intra-arterial alcoholization of advanced hepatocellular carcinoma. Cancer Chemother Pharmacol 33 suppl (1994) S42-S47
10. Kan Z., Ivancev K., and Lunderquist A. Peribiliary plexa-important pathways for shunting of iodized oil and silicon rubber solution from the hepatic artery to the portal vein: an experimental study in rats. Invest Radiol 29 (1994) 671-676
11. Kan Z., and Wallace S. Transcatheter liver lobar ablation: an experimental trial in an animal model. Eur Radiol 7 (1997) 1071-1075
12. Cheng Y., Kan Z., Chen C., et al. Efficacy and safety of preoperative lobar or segmental ablation via transarterial administration of Ethiodol and ethanol mixture for treatment of hepatocellular carcinoma: clinical study. World J Surg 24 (2000) 844-850
13. Cheung Y.C., Ko S.F., Ng S.H., Chan S.C., and Cheng Y.F. Survival outcome of lobar or segmental transcatheter arterial embolization with ethanol-Lipiodol mixture in treating hepatocellular carcinoma. World J Gastroenterol 11 (2005) 2792-2795
14. Miller A.B., Hoogstraten B., Staquet M., and Winkler A. Reporting results of cancer treatment. Cancer 47 (1987) 207-214
15. Yu S.C.H., Hui E.P., Wong J., et al. Transarterial ethanol ablation of hepatocellular carcinoma with lipiodol-ethanol mixture: phase II study. J Vasc Interv Radiol 19 (2008) 95-103
16. Ramsey D.E., Kernagis L.Y., Soulen M.C., and Geschwind J.H. Chemoembolization of hepatocellular carcinoma. J Vasc Interv Radiol 13 suppl (2002) S211-S221
17. Konno T. Targeting cancer chemotherapeutic agents by use of lipiodol contrast medium. Cancer 66 (1990) 1897-1903
18. Egawa H., Maki A., and Mori K. Effects of intraarterial chemotherapy with a new lipophilic anticancer agent, estradiolchlorambucil (KM2210), dissolved in lipiodol on experimental liver tumor in rats. J Surg Oncol 44 (1990) 109-114
19. Nakamura H., Hashimoto T., Oi H., and Sawada S. Transcatheter oily chemoembolization of hepatocellular carcinoma. Radiology 170 (1989) 783-786
20. Sasaki Y., Imaoka S., Kasugai H., et al. A new approach to chemoembolization therapy for hepatoma using ethiodized oil, cisplatin, and gelatin sponge. Cancer 60 (1987) 1194-1203
21. Mathupala S.P., Rempel A., and Pedersen P.L. Glucose catabolism in cancer cells: identification and characterization of a marked activation response of the type II hexokinase gene to hypoxic conditions. J Biol Chem 276 (2001) 43407-43412
22. Tajima T., Honda H., Taguchi K., et al. Sequential hemodynamic change in hepatocellular carcinoma and dysplastic nodules: CT angiography and pathologic correlation. AJR Am J Roentgenol 178 (2002) 885-897
23. Tanaka K., Okazaki H., Nakamura S., et al. Hepatocellular carcinoma: treatment with a combination therapy of transcatheter arterial embolization and percutaneous ethanol injection. Radiology 179 (1991) 713-717
24. Lencioni R., Vignali C., Caramella D., Cioni R., Mazzeo S., and Bartolozzi C. Transcatheter arterial embolization followed by percutaneous ethanol injection in the treatment of hepatocellular carcinoma. Cardiovasc Intervent Radiol 1 (1994) 70-75
25. Tanaka K., Nakamura S., Numata K., et al. Hepatocellular carcinoma: treatment with percutaneous ethanol injection and transcatheter arterial embolization. Radiology 185 (1992) 457-460
26. Hasuike Y., Okamura J., Furukawa J., et al. Efficacy of combination treatment (TAE with Adriamycin and ethanol) for hepatocellular carcinoma. Cancer Chemother Pharmacol 31 suppl (1992) S30-S34
27. Bartolozzi C., Lencioni R., Caramella D., et al. Treatment of large HCC: transcatheter arterial chemoembolization combined with percutaneous ethanol injection versus repeated transcatheter arterial chemoembolization. Radiology 197 (1995) 812-818
28. Ngan H., Lai C.L., Fan S.T., Lai E.C., Yuen W.K., and Tso W.K. Treatment of inoperable hepatocellular carcinoma by transcatheter arterial chemoembolization using an emulsion of cisplatin in iodized oil and Gelfoam. Clin Radiol 47 (1993) 315-320
29. Vogl T.J., Trapp M., Schroeder H., et al. Transarterial chemoembolization for hepatocellular carcinoma: volumetric and morphologic CT criteria for assessment of prognosis and therapeutic success-results from a liver transplantation center. Radiology 214 (2000) 349-357
30. Choi B.J., Kim H.C., Han J.K., et al. Therapeutic effect of transcatheter oily chemoembolization therapy for encapsulated nodular hepatocellular carcinoma: CT and pathological findings. Radiology 182 (1992) 709-713
31. Imamura H., Matsuyama Y., Tanaka E., et al. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol 38 (2003) 200-207
32. Llovet J.M., Schwartz M., and Mazzaferro V. Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis 25 (2005) 181-200
33. Llovet J.M., Di Bisceglie A.M., Bruix J., et al. Design and endpoints of clinical trials in hepatocellular carcinoma. J Natl Cancer Inst 100 (2008) 698-711
34. Chan A.O., Yuen M.F., Hui C.K., Tso W.K., and Lai C.L. A prospective study regarding the complications of transcatheter intraarterial lipiodol chemoembolization in patients with hepatocellular carcinoma. Cancer 94 (2002) 1747-1752